Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.

Pauer L, Winkelmann A, Arsenault P, Jespersen A, Whelan L, Atkinson G, Leon T, Zeiher B; A0081100 Investigators.

J Rheumatol. 2011 Dec;38(12):2643-52. doi: 10.3899/jrheum.110569. Epub 2011 Oct 1.

PMID:
21965636
2.

Evidence based guidelines for complex regional pain syndrome type 1.

Perez RS, Zollinger PE, Dijkstra PU, Thomassen-Hilgersom IL, Zuurmond WW, Rosenbrand KC, Geertzen JH; CRPS I task force.

BMC Neurol. 2010 Mar 31;10:20. doi: 10.1186/1471-2377-10-20.

3.

[Short-term steroid therapy, sometimes with long-term sequelae].

van Schaardenburg D, van den Brink HR, Wieringa HJ.

Ned Tijdschr Geneeskd. 2001 Sep 15;145(37):1769-73. Review. Dutch.

PMID:
11582637
4.

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.

Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, van Zeben D, Dijkmans BA, Peeters AJ, Jacobs P, van den Brink HR, Schouten HJ, van der Heijde DM, Boonen A, van der Linden S.

Lancet. 1997 Aug 2;350(9074):309-18. Erratum in: Lancet 1998 Jan 17;351(9097):220.

PMID:
9251634
5.

Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis.

ten Wolde S, Breedveld FC, Hermans J, Vandenbroucke JP, van de Laar MA, Markusse HM, Janssen M, van den Brink HR, Dijkmans BA.

Lancet. 1996 Feb 10;347(8998):347-52.

PMID:
8598699
6.
7.

Adjuvant oestrogen therapy does not improve disease activity in postmenopausal patients with rheumatoid arthritis.

van den Brink HR, van Everdingen AA, van Wijk MJ, Jacobs JW, Bijlsma JW.

Ann Rheum Dis. 1993 Dec;52(12):862-5.

8.

Influence of disease activity on steroid hormone levels in peripheral blood of patients with rheumatoid arthritis.

van den Brink HR, Blankenstein MA, Koppeschaar HP, Bijlsma JW.

Clin Exp Rheumatol. 1993 Nov-Dec;11(6):649-52.

PMID:
8299259
9.

Effect of hormone replacement therapy on markers of bone metabolism in RA.

Lems WF, van den Brink HR, Gerrits MI, van Rijn HJ, Bijlsma JW.

Ann Rheum Dis. 1993 Nov;52(11):835-6. No abstract available.

10.

Transient decrease in osteocalcin and markers of type 1 collagen turnover during high-dose corticosteroid pulse therapy in rheumatoid arthritis.

Lems WF, Jacobs JW, van den Brink HR, van Rijn HJ, Bijlsma JW.

Br J Rheumatol. 1993 Sep;32(9):787-9.

PMID:
8369888
11.

Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis.

van den Brink HR, Lems WF, van Everdingen AA, Bijlsma JW.

Ann Rheum Dis. 1993 Apr;52(4):302-5.

12.

Evaluation of the Thompson articular index.

van den Brink HR, van der Heide A, Jacobs JW, van der Veen MJ, Bijlsma JW.

J Rheumatol. 1993 Jan;20(1):28-32.

PMID:
8441161
13.

Influence of steroid hormones on proliferation of peripheral blood mononuclear cells in patients with rheumatoid arthritis.

van den Brink HR, van Wijk MJ, Bijlsma JW.

Br J Rheumatol. 1992 Oct;31(10):663-7.

PMID:
1393371
14.

Estrogens and rheumatoid arthritis.

Bijlsma JW, Van den Brink HR.

Am J Reprod Immunol. 1992 Oct-Dec;28(3-4):231-4. Review.

PMID:
1285887
15.

Eosinophilic fasciitis presenting with a reactive hepatitis.

Loeliger AE, van den Brink HR, Derksen RH, Bijlsma JW.

Clin Rheumatol. 1991 Dec;10(4):440-4.

PMID:
1802502
16.

[Rheumatoid arthritis and pregnancy; a problem?].

van den Brink HR, Bijlsma JW.

Ned Tijdschr Geneeskd. 1991 Feb 23;135(8):313-7. Dutch. No abstract available.

PMID:
2008218
17.

Can oestrogens be used as adjuvant therapy in female patients with rheumatoid arthritis?

van den Brink HR, Bijlsma JW.

Br J Rheumatol. 1989;28 Suppl 1:24-7. Review.

PMID:
2684316
18.

Development of T and B cell areas in peripheral lymphoid organs of the rat.

Eikelenboom P, Levenbach MG, van den Brink HR, Streefkerk JG.

Anat Rec. 1979 Aug;194(4):523-38.

PMID:
382912

Supplemental Content

Loading ...
Support Center